the Overlooked Danger: Rising Stimulant Use complicates the Opioid crisis
The opioid epidemic continues to grip North America, claiming tens of thousands of lives annually. However, a concerning trend is emerging: a significant number of individuals struggling with opioid misuse are also using stimulants, and tragically, succumbing to stimulant-related fatalities. Recent research, detailed in PLOS Mental Health [[1]],highlights the critical need to address this often-hidden aspect of the drug crisis.
A Dual Threat: Opioids and Stimulants in Combination
In 2021 alone, over 88,000 deaths in the United States and Canada were linked to opioid-related causes – representing the peak of three successive waves of opioid-related mortality. What’s often less recognized is the widespread co-use of stimulants among those using opioids. Studies indicate that approximately 82% of opioid users have experimented with stimulants, with around 22% reporting regular amphetamine use. This combination dramatically increases the risk of overdose and death.
To investigate the connection between opioid and stimulant fatalities, researchers analyzed data spanning from 1999 to 2021 from the United States National Institute on Drug Abuse, alongside data from the Public Health Agency of Canada and the Alberta substance Use Surveillance System (2016-2021). They supplemented this data with Google Trends details to gauge public awareness surrounding deaths involving both drug classes.
Shifting Patterns of Drug-Related Deaths
The analysis revealed a distinct pattern of surges in drug-related deaths. Four major increases in opioid-related deaths were identified, with the moast substantial occurring between 2019 and 2021. Together, three surges in stimulant-related deaths were observed between 1999 and 2021, the largest of which took place between 2013 and 2021. notably, two significant increases were recorded in deaths involving both opioids and stimulants, with the most pronounced rise occurring between 2013 and 2021.
This data suggests a concerning convergence of these two drug crises. consider the analogy of battling two simultaneous wildfires – resources are stretched thin, and the combined intensity makes containment far more challenging. Similarly, the co-occurrence of opioid and stimulant use demands a more thorough and integrated public health response.
A “Silent Epidemic” Fueled by Lack of Awareness
A especially alarming finding was the disparity between public awareness of opioid deaths and stimulant-related fatalities. While Google Trends data showed spikes in searches related to opioids during periods of increased opioid-related deaths, searches for stimulants remained consistently low. This indicates a significant lack of public understanding regarding the dangers of stimulant use, and particularly the risks associated with combining them with opioids.
The study acknowledges limitations, including the lack of comprehensive data on the use of other substances like alcohol and a concentration of data from the United States. However, the findings strongly suggest that the escalating stimulant-related deaths are occurring largely “under the radar,” and this lack of public awareness may be hindering effective intervention strategies.
As of early 2024, provisional data from the CDC indicates that stimulant-involved overdose deaths continue to rise, with synthetic opioids like fentanyl frequently found in combination with stimulants. [[2]] Addressing this complex issue requires a multi-faceted approach, including increased public education, expanded access to treatment, and harm reduction strategies tailored to the unique challenges posed by stimulant use.References:
[[1]] Li, Y., et al. (2025) Co-involvement of stimulants with opioids in North America: A ‘silent epidemic’. PLOS Mental Health.
[2]] Centers for Disease Control and Prevention. (2024). Drug Overdose Data. Retrieved from [https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm